Suchergebnisse - "Eibl, Guido"

PubPharm (59)

1

Low dosage combination treatment with metformin and simvastatin inhibits obesity-promoted pancreatic cancer development in male KrasG12D mice

enthalten in: Scientific reports | 2023

von Teper, Y. | Ye, L. | Waldron, R. | +7

2

Opposite Effects of Src Family Kinases on YAP and ERK Activation in Pancreatic Cancer Cells : Implications for Targeted Therapy

enthalten in: Molecular cancer therapeutics | 2022

von Sinnett-Smith, J. | Anwar, T. | Reed, E. | +3

3

Body Mass Index Trajectories Across the Adult Life Course and Pancreatic Cancer Risk

enthalten in: JNCI cancer spectrum | 2022

von Arjani, S. | Saint-Maurice, P. | Julián-Serrano, S. | +2

4

Metformin : review of epidemiology and mechanisms of action in pancreatic cancer

enthalten in: Cancer metastasis reviews | 2021

von Eibl, G. | Rozengurt, E.

5

Direct Effects of Lipopolysaccharide on Human Pancreatic Cancer Cells

enthalten in: Pancreas | 2021

von Massoumi, R. | Teper, Y. | Ako, S. | +4

6

Nutritional Support and Probiotics as a Potential Treatment of IBD

enthalten in: Current drug targets | 2020

von Tarasiuk, A. | Eibl, G.

7

Metformin alters the duodenal microbiome and decreases the incidence of pancreatic ductal adenocarcinoma promoted by diet-induced obesity

enthalten in: American journal of physiology. Gastrointestinal and liver physiology | 2019

von Dong, T. | Chang, H. | Hauer, M. | +5

8

Animal Models : Challenges and Opportunities to Determine Optimal Experimental Models of Pancreatitis and Pancreatic Cancer

enthalten in: Pancreas | 2019

von Saloman, J. | Albers, K. | Cruz-Monserrate, Z. | +14

9

Obesity-Induced Adipose Tissue Inflammation as a Strong Promotional Factor for Pancreatic Ductal Adenocarcinoma

enthalten in: Cells | 2019

von Chang, H. | Eibl, G.

10

KRAS, YAP, and obesity in pancreatic cancer : A signaling network with multiple loops

enthalten in: Seminars in cancer biology | 2019

von Eibl, G. | Rozengurt, E.

1
2
3
4
5
6
Nächster »
[6]